Evidence map›Paper›PMID 28861150›Full record

ArticleAmerican journal of translational research2017

MicroRNA-130a-3p suppresses cell viability, proliferation and invasion in nasopharyngeal carcinoma by inhibiting

Rongfeng Qu, Yan Sun, Yarong Li, Chunmei Hu, Guang Shi, Yan Tang, Dongrui Guo

Open access · greenAbstract read
In one paragraph

Article in American journal of translational research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Identification of serum exosomal microRNAs in acute spinal cord injured rats.Experimental biology and medicine (Maywood, N.J.) · 2019
    Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Rongfeng QuDepartment of Hematology and Oncology, The Second Hospital of Jilin UniversityChangchun 130041, Jilin, China.
Yan SunDepartment of Hematology and Oncology, The Second Hospital of Jilin UniversityChangchun 130041, Jilin, China.
Yarong LiDepartment of Hematology and Oncology, The Second Hospital of Jilin UniversityChangchun 130041, Jilin, China.
Chunmei HuDepartment of Hematology and Oncology, The Second Hospital of Jilin UniversityChangchun 130041, Jilin, China.
Guang ShiDepartment of Hematology and Oncology, The Second Hospital of Jilin UniversityChangchun 130041, Jilin, China.
Yan TangDepartment of Hematology and Oncology, The Second Hospital of Jilin UniversityChangchun 130041, Jilin, China.
Dongrui GuoDepartment of Hematology and Oncology, The Second Hospital of Jilin UniversityChangchun 130041, Jilin, China.
Second Affiliated Hospital of Jilin University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Incidence of nasopharyngeal carcinoma (NPC) has remained high worldwide, posing a serious health problem. MicroRNAs (miRNAs) are a family of about 20-23 nucleotides small non-coding molecules, which play a significant role in NPC. In this study, we explored the molecular mechanisms of miR-130a-3p in inhibiting viability, proliferation, migration and invasion of NPC cells by suppressing

Indexed as

CXCL12invasionmigrationmiR-130a-3pNasopharyngeal carcinomaproliferation

Identifiers

PMID28861150
PMCPMC5575173
OpenAlexW2990373393

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.